Ibiotech Instytutsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-02-21
Share capital
5,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
4 of 4 financial statements were filed late (the longest delay 340 days for 2024).
- 202520/07/2026
- 202420/06/2026
- 202316/07/2024
- 202216/01/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering523 / 1,564
Top 33%
Results vs industry
Revenue
This companyUSD 223.19kMedianUSD 73.59kAverageUSD 3.23m
Net profit
This companyUSD 38.67kMedianUSD 69.14AverageUSD 82.20k
Operating costs
This companyUSD 184.52kMedianUSD 76.19kAverageUSD 3.05m
Assets
This companyUSD 30.98kMedianUSD 120.44kAverageUSD 3.90m
Industry
Authorized Representatives
Donata Sławomira Strycharczykage 43 – Management Board Member
Karolina Musielewiczage 38 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Karolina Musielewiczage 38 | 51 | $688.82 | 51% |
| 49 | $661.80 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 29, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,144$3,144 | Rzeszowska Agencja Rozwoju Regionalnego S.A. | |
| Feb 28, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $21,983$21,983 | Rzeszowska Agencja Rozwoju Regionalnego S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eurxsp. z o.o. | $1,644,555.44 | eurx.com.pl | ||
| Medsource Polskasp. z o.o. | $1,620,329.12 | medsource.com.pl | ||
| Wasatsp. z o.o. | $989,794.30 | wasat.pl | ||
| Indoornavisp. z o.o. | $932,972.68 | indoornavi.me | ||
| Gcp-Service International Ltd. & Co. KgBranch (foreign co.) | $159,376.34 | gcp-service.com | ||
| TCIsp. z o.o. | $143,197.19 | tci.pl | ||
| Centrum Badawczo Rozwojowe Future Solutionssp. z o.o. | $63,890.38 | cbrfs.com | ||
| Basic Solutionsp. z o.o. | $31,812.74 | basicsolution.eu | ||
| Bałtycka Agencja Poszanowania Energiisp. z o.o. | $28,346.34 | bape.com.pl | ||
| Mhb-Rdsp. z o.o. | $2,498.80 | mhb-rd.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-28 | Address change (Ul. Henryka Wieniawskiego 16c/8, 76-150, Darłowo → Aleja Jana Pawła Ii 3a/27, 80-462, Gdańsk) | |
| 2023-06-23 | Address change (Ul. Juliusza Słowackiego 24, 35-069, Rzeszów → Ul. Henryka Wieniawskiego 16c/8, 76-150, Darłowo) | |
| 2023-06-23 | Name change (Yesdigital → Ibiotech Instytut) | |
| 2023-06-23 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2022-02-21 | Entered in the register |
FAQ
The main business activity of Ibiotech Instytut focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on February 21, 2022.
The headquarters is located at: Aleja Jana Pawła Ii 3A, 80-462 Gdańsk.
The management board consists of: Donata Sławomira Strycharczyk (Member of the Management Board) and Karolina Musielewicz (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $223,195, representing an increase of 199.6% compared to 2024.
Yes, the company recorded a net profit of $38,670 in 2025, meaning the company increased its profit by 430.1%.
The largest operating cost category falls under other operating costs. This category amounted to $138,819 in 2025, representing 75% of all operating expenses.
Last updated: 2026-07-20
